scicann.net
About company
SciCann is a Canadian–Israeli pharmaceutical company that develops and commercializes pharmaceutical products that target and modulate the endocannabinoid system that include new therapeutic agents, drug candidates, novel cannabis genetics, and personalized treatment tools. It is active in the fields of oncology, pain management, neurodegenerative diseases, and inflammatory disorders. It develops a line of proprietary products for the treatment of chosen life-threatening conditions that present a high level of unmet need. SciCann holds a diversified portfolio of intellectual property and ownerships in ventures operating in cannabinoid science. It maintains a wide network of strategic and synergistic collaborations with research institutes and commercial companies in the space. It performs its research and development in Israel with commercialization in Canada.
